Loxo Oncology Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
30.47 M |
Public Float |
21.8 M |
Loxo Oncology Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.65 |
Market Cap |
$5.2 B |
Shares Outstanding |
30.47 M |
Public Float |
27.26 M |
Address |
281 Tresser Boulevard Stamford Connecticut 06901 United States |
Employees | - |
Website | http://www.loxooncology.com |
Updated | 09/14/2018 |
Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. |